India’s private hospitals possess the infrastructure and expertise to become global contributors to medical research. But their research capacity remains underutilised. The future of healthcare depends on embedding scientific inquiry into routine clinical practice — transforming hospitals into learning health systems where every patient encounter contributes to the advancement of medicine.
Dr Sami Ullah; Dr Murtuza Habib
In a recent opinion article titled “From Care to Discovery: Why Research Must Become the Next Pillar of India’s Private Healthcare” the authors argued that India’s rapidly expanding private healthcare sector has reached a pivotal moment in its evolution. While substantial investments have transformed many private hospitals into centres of excellence for advanced diagnostics, precision imaging, minimally invasive interventions, and highly specialised therapeutics, their capacity to generate high-quality scientific evidence remains considerably underutilised. As healthcare increasingly transitions towards precision medicine, learning health systems, real-world evidence, and data-driven clinical decision-making, hospitals can no longer be viewed solely as providers of healthcare services. They must also function as engines of discovery, continuously converting routine clinical practice into knowledge that advances medicine. Contemporary scientific literature consistently demonstrates that integrating research into everyday healthcare delivery strengthens clinical governance, accelerates innovation, improves patient outcomes, and enhances health-system resilience. The future of high-quality healthcare, therefore, will depend not only on adopting medical innovations but also on generating robust evidence capable of informing clinical practice, shaping health policy, and addressing emerging health challenges within diverse population settings.
The imperative for this transformation has become even more compelling in light of evolving global health priorities. Recent assessments by the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) project a substantial rise in the global burden of cancer by 2050, with the steepest increases anticipated in low and middle-income countries where inequities in prevention, early detection, diagnosis, treatment, survivorship care, and research capacity remain pronounced. These projections extend beyond oncology and reflect a broader epidemiological transition characterised by the increasing prevalence of non-communicable diseases, ageing populations, antimicrobial resistance, and emerging health threats. Collectively, they underscore the need for resilient health systems capable of generating context-specific evidence alongside delivering high-quality clinical care.
Responding to these challenges requires a paradigm shift from healthcare systems that primarily provide services to those that continuously generate knowledge. Contemporary literature also increasingly recognises that sustainable improvements in health outcomes cannot be achieved through expansion of clinical infrastructure alone. Instead, progress depends upon embedding scientific inquiry within routine healthcare delivery through learning health systems, implementation science, real-world evidence generation, precision medicine, and multidisciplinary translational research. Locally generated evidence is indispensable for understanding population-specific disease patterns, evaluating interventions under real-world conditions, reducing health inequities, and informing responsive public health policy.
Against this backdrop, the strategic importance of private healthcare institutions warrants renewed scientific and policy attention. Across India, private hospitals now manage a substantial proportion of the country’s healthcare burden while possessing advanced diagnostic platforms, specialised clinical expertise, digital health infrastructure, and access to diverse patient populations. These attributes position them not merely as providers of healthcare services but as potentially powerful contributors to scientific discovery. Harnessing this largely untapped research capacity would strengthen evidence-based practice, accelerate clinical innovation, improve quality of care, and enable India to contribute more substantially to the global scientific enterprise while addressing its own evolving healthcare priorities.
India is uniquely positioned to contribute to this global agenda. Over the past decade, private hospitals have invested substantially in advanced diagnostic technologies, multidisciplinary specialist services, minimally invasive procedures, molecular diagnostics, precision imaging, and digital health infrastructure that were once largely confined to tertiary academic centres. These investments have significantly enhanced the quality of patient care and expanded access to sophisticated medical services across the country.
Despite these advancements, an important opportunity remains underutilized. Every day, private hospitals generate enormous volumes of real-world clinical data through routine patient care. However, a considerable proportion of these observations remain undocumented in peer-reviewed literature, are not systematically analysed, and therefore do not contribute to the broader scientific evidence base. This represents a missed opportunity not only for advancing medical knowledge but also for improving healthcare delivery, informing policy, and strengthening evidence-based clinical practice.
However, the reasons for this gap are multifactorial and have been widely recognised in international and national literature. Heavy clinical workloads, limited protected time for research, inadequate institutional research infrastructure, insufficient funding mechanisms, regulatory complexities, and the absence of dedicated research personnel often constrain clinician-led scientific inquiry within private healthcare settings. These barriers, however, are increasingly surmountable through institutional commitment, strategic investment, academic partnerships, and the integration of research into routine clinical workflows.
Embedding research within private healthcare systems offers dividends that extend well beyond scientific publications. It enables continuous evaluation of diagnostic accuracy, assessment of therapeutic effectiveness, monitoring of long-term patient outcomes, identification of region-specific disease patterns, optimisation of healthcare delivery, and acceleration of innovation through real-world evidence. Every patient encounter represents an opportunity to generate knowledge capable of improving care for countless future patients. When these opportunities are systematically harnessed, hospitals evolve from centres of treatment into learning health systems that continuously refine clinical practice through evidence. Conversely, when these opportunities remain untapped, an invaluable reservoir of scientific knowledge is lost. Such lost knowledge could greatly refine clinical decision-making, strengthen health systems, inform public policy, and ultimately aid in improving patient outcomes at regional, national, and global levels. In an era increasingly defined by precision medicine and evidence-based healthcare, every clinical encounter has the potential to contribute not only to individual patient care but also to the advancement of medical science.
One of the most significant transformations in contemporary medicine has been the rapid evolution of non-invasive diagnostic technologies. Modern clinical practice increasingly depends on sophisticated imaging and functional diagnostic modalities that enable clinicians to characterize disease with remarkable precision while minimizing patient discomfort, procedural risks, and recovery time. Technologies including computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT), high-resolution ultrasonography, digital pathology, advanced endoscopy, molecular imaging, artificial intelligence (AI)-assisted image analysis, radiomics, and quantitative imaging biomarkers are fundamentally redefining disease detection, diagnosis, therapeutic planning, prognostication, and longitudinal patient monitoring.
The scientific value of these technologies extends well beyond their diagnostic capabilities. Contemporary research demonstrates that advanced imaging platforms can generate high-dimensional quantitative data capable of revealing subtle anatomical, functional, and molecular characteristics that are often imperceptible to conventional visual interpretation. The convergence of radiomics, imaging genomics, machine learning, digital pathology, and multimodal data integration is creating unprecedented opportunities to identify imaging biomarkers, predict therapeutic response, stratify disease risk, monitor treatment efficacy, and support increasingly personalized approaches to clinical care. These advances are already reshaping fields such as oncology, neurology, cardiology, hepatology, pulmonology, musculoskeletal medicine, and infectious diseases.
Importantly, realizing this scientific potential does not necessarily require substantial additional investment in expensive infrastructure. Rather, it depends on systematically leveraging technologies that many private hospitals already possess by integrating robust research methodologies into routine clinical practice. Carefully designed observational studies, prospective clinical registries, outcome analyses, validation of diagnostic algorithms, translational research, and real-world evidence generation can transform everyday diagnostic workflows into valuable scientific assets. Such an approach enables healthcare institutions not only to improve the quality and effectiveness of patient care but also to contribute meaningful evidence that informs clinical guidelines, public health policy, and future medical innovation.
However, establishing and maintaining such sophisticated diagnostic capabilities requires substantial financial investment, specialised expertise, and sustained technological upgradation, making their universal availability across all public healthcare institutions particularly challenging in resource-constrained settings. In contrast, many private hospitals have progressively developed comprehensive diagnostic ecosystems comprising advanced imaging platforms, molecular diagnostic laboratories, minimally invasive therapeutic facilities, digital pathology services, and integrated electronic health information systems. These investments position the private healthcare sector not only as a major provider of specialised clinical care but also as a potentially powerful contributor to biomedical research, translational medicine, and real-world evidence generation.
Encouragingly, this transformation has begun to emerge within Jammu & Kashmir. Institutions such as Paras Health, Srinagar have started recognising that excellence in clinical care and excellence in scientific inquiry are mutually reinforcing rather than mutually exclusive. Alongside expanding advanced tertiary-care services, initiatives aimed at strengthening research capacity, fostering academic collaborations, and promoting an institutional culture of evidence generation represent important steps towards integrating research into routine healthcare delivery. Such developments provide an encouraging model for how private healthcare institutions can evolve from centres of treatment into centres of discovery.
The next phase of healthcare evolution must therefore extend beyond clinical excellence to encompass research excellence. Contemporary healthcare is increasingly being shaped by precision medicine, implementation science, learning health systems, and artificial intelligence, all of which depend upon the continuous generation of high-quality clinical evidence. Private hospitals possess an unprecedented opportunity to transform routine clinical practice into engines of innovation by establishing dedicated clinical research units, multidisciplinary investigator teams, institutional ethics frameworks, biobanks, disease registries, imaging repositories, secure health-data platforms, and strategic collaborations with universities, biotechnology industries, public health agencies, and international research networks. Embedding research within routine healthcare delivery would not only strengthen evidence-based medicine and accelerate translational science but also facilitate context-specific innovation, improve healthcare quality, support regulatory science, and generate locally relevant evidence capable of addressing the evolving health priorities of India while contributing meaningfully to the global scientific literature.
Future Perspectives
The future of medicine will be defined not merely by the acquisition of increasingly sophisticated technologies, but by the ability of healthcare systems to transform routine clinical care into actionable scientific knowledge. Contemporary healthcare is rapidly transitioning towards learning health systems in which patient care, research, digital innovation, and continuous quality improvement operate as an integrated ecosystem. Within this evolving paradigm, India’s private healthcare sector is uniquely positioned to become a major contributor to biomedical discovery by leveraging its extensive clinical infrastructure, diverse patient populations, advanced diagnostic capabilities, and expanding digital health platforms.
Over the coming decade, the convergence of artificial intelligence, machine learning, multimodal foundation models, digital pathology, radiomics, genomics, proteomics, wearable health technologies, remote patient monitoring, and real-world evidence is expected to fundamentally reshape healthcare delivery. Hospitals will increasingly be assessed not only by the quality, safety, and efficiency of the care they provide, but also by their capacity to generate reproducible evidence, validate emerging technologies, accelerate translational research, and inform clinical practice and public health policy. Institutions that successfully integrate research into routine healthcare delivery will be better positioned to drive precision medicine, improve health-system resilience, reduce healthcare inequities, and contribute meaningfully to both national priorities and the global scientific enterprise.
The question is therefore no longer whether research should accompany clinical care, but how rapidly healthcare institutions can embed scientific inquiry into everyday practice. Those that embrace this transformation will not simply deliver better healthcare but they will help define the future of medicine itself.
For India, and particularly for Jammu & Kashmir, this transition represents both a scientific imperative and a public health opportunity. The region is witnessing an evolving epidemiological landscape characterised by a rising burden of cancer, cardiovascular diseases, diabetes, chronic kidney disease, mental health disorders, trauma, substance use disorders, and other non-communicable diseases, alongside persistent infectious diseases and unique environmental and geographical health challenges. Yet, much of the evidence guiding clinical practice continues to originate from populations with different genetic, demographic, environmental, and sociocultural characteristics. This underscores the urgent need for locally generated, context-specific research capable of informing precision healthcare and regionally relevant health policies.
The rapid expansion of private healthcare infrastructure across Jammu & Kashmir, together with sustained investments in advanced diagnostics, molecular medicine, high-end imaging, minimally invasive interventions, and specialist clinical services, provides an unprecedented opportunity to establish hospital-based research ecosystems. Developing dedicated clinical research units, multidisciplinary investigator teams, biobanks, disease registries, imaging repositories, secure digital health-data platforms, and collaborative networks with academic institutions would transform hospitals into learning health systems where every patient encounter contributes to scientific discovery. Such an approach would not only strengthen evidence-based clinical practice and improve patient outcomes but also position Jammu & Kashmir as an emerging contributor to national and global biomedical research, ensuring that innovations generated from its healthcare system benefit both its own population and the wider scientific community.
Future research must increasingly embrace multidisciplinary and transdisciplinary collaboration by bringing together clinicians, epidemiologists, biomedical scientists, public health experts, data scientists, bioinformaticians, radiologists, pathologists, forensic scientists, behavioural scientists, implementation researchers, health economists, and artificial intelligence specialists. Such convergence will accelerate the development of precision medicine, predictive and preventive healthcare, digital health innovations, implementation science, and learning health systems in which evidence generated from routine clinical care continuously informs, refines, and improves subsequent patient management.
Beyond advancing scientific discovery, this integrated approach will facilitate the identification of population-specific disease determinants, validation of novel diagnostic and prognostic biomarkers, optimisation of therapeutic pathways, evaluation of health-system performance, and generation of high-quality real-world evidence to support regulatory decision-making and evidence-based policy. Importantly, it will strengthen preparedness for emerging health challenges, foster responsible adoption of artificial intelligence and big-data analytics, promote equitable and patient-centred care, and bridge the long-standing gap between research, clinical practice, and public health. Ultimately, embedding multidisciplinary research within routine healthcare delivery will transform hospitals into continuously learning institutions capable of driving innovation, improving population health, and contributing meaningfully to both national priorities and the global scientific literature.
Emerging digital technologies are poised to fundamentally reshape the future of clinical research. Large Language Models (LLMs), when deployed within rigorous ethical, regulatory, and privacy-preserving frameworks, have the potential to augment, rather than replace, human expertise by accelerating literature synthesis, supporting clinical documentation, facilitating protocol development, enhancing patient education, improving pharmacovigilance, assisting clinical decision support, and generating research hypotheses for subsequent scientific validation. Likewise, advances in explainable artificial intelligence, federated learning, multimodal foundation models, digital twins, and privacy-enhancing technologies offer unprecedented opportunities for collaborative research across institutions while safeguarding patient confidentiality, ensuring data sovereignty, and maintaining public trust. These technologies can unlock the scientific value of routinely collected clinical data, enabling scalable real-world evidence generation, predictive analytics, and precision healthcare without compromising information security or ethical standards.
Equally indispensable is the establishment of robust research governance as the cornerstone of responsible innovation. Modern healthcare institutions should develop comprehensive research ecosystems comprising independent Institutional Ethics Committees, Good Clinical Practice (GCP)-compliant clinical research units, secure and interoperable data infrastructures aligned with the FAIR (Findable, Accessible, Interoperable, and Reusable) data principles, standardized biobanking and data governance protocols, transparent publication and authorship policies, continuous professional training in research methodology and responsible conduct of research, and rigorous quality assurance mechanisms. Such investments should not be regarded as discretionary academic expenditure but as strategic investments in patient safety, clinical excellence, institutional accountability, regulatory preparedness, healthcare resilience, and national scientific competitiveness. Ultimately, hospitals that successfully integrate trustworthy artificial intelligence with strong research governance will be best positioned to drive innovation, generate high-quality evidence, and deliver safer, more effective, and more equitable healthcare in the era of precision medicine.
It may not be out of place to submit here that the future of healthcare will be shaped not only by the number of patients treated, but by the knowledge generated from every clinical encounter. Hospitals that systematically convert clinical experience into scientific evidence will drive innovation, improve health outcomes, and strengthen resilience against emerging diseases. India’s private healthcare sector possesses the infrastructure, expertise, and patient diversity to become a global contributor to translational medicine and evidence-based healthcare. The next frontier is therefore clear: hospitals must evolve beyond centres of treatment to become engines of discovery, innovation, and continuous learning—where every patient encounter contributes not only to individual recovery but also to the advancement of medicine itself.
In light of the foregoing discussion, one conclusion that emerges with increasing clarity from contemporary scientific literature is that the future of healthcare will be determined not only by the capacity to deliver advanced clinical services but also by the ability of health systems to continuously generate, translate, and apply new knowledge. As the global burden of cancer, non-communicable diseases, antimicrobial resistance, emerging infectious threats, and ageing populations continues to rise, strengthening research ecosystems has become an essential prerequisite for resilient, equitable, and sustainable healthcare. Across the world, precision diagnostics, artificial intelligence, real-world evidence, implementation science, translational research, and learning health systems are redefining modern medicine by transforming routine clinical practice into a continuous cycle of discovery, evaluation, innovation, and quality improvement.
For India’s private healthcare sector, this represents both a strategic responsibility and an extraordinary opportunity. By embedding research as a core institutional function, private hospitals can move beyond delivering high-quality care to actively generating the evidence that shapes future clinical practice, informs health policy, accelerates responsible innovation, and improves population health. Hospitals that integrate scientific inquiry into everyday healthcare delivery will be better positioned to develop context-specific solutions, evaluate emerging technologies, strengthen patient safety, and respond more effectively to evolving healthcare challenges. The defining healthcare institutions of the twenty-first century will therefore be those that seamlessly unite clinical excellence with scientific discovery, recognising that every patient encounter is not only an opportunity to heal an individual but also to generate knowledge capable of improving the health of entire populations.
Encouragingly, this transformation is beginning to gain momentum within segments of India’s private healthcare sector. At Paras Health, Srinagar, initiatives are underway to strengthen institutional research and academic capacity alongside the continued expansion of advanced clinical services. Such efforts reflect an evolving recognition that excellence in patient care and excellence in scientific inquiry are mutually reinforcing pillars of a contemporary health system. Developing structured research programmes, fostering academic collaborations, and cultivating a culture of evidence generation have the potential to enhance clinical quality, promote innovation, and support context-specific healthcare solutions. If replicated across the wider private healthcare landscape, this integrated model could reposition hospitals from centres focused primarily on service delivery to learning health systems that continuously generate knowledge, improve clinical practice, and contribute meaningfully to national and global medical science.
Dr Sami Ullah is a Research Consultant (Locum) and Dr Murtuza Habib is the Facility Director at Paras Health, Srinagar. The institution is strengthening its research and academic ecosystem to support clinical research, evidence generation, interdisciplinary collaboration, and the advancement of evidence-based healthcare in Jammu & Kashmir.
sa********@***il.com